Neonc Technologies Holdings, .
Neonc Technologies Holdings, .15
Neonc Technologies Holdings, .
Clinical-stage life sciences company developing a novel intranasal drug delivery system for brain cancers and CNS diseases.
About
Pricing
View pricing page ↗
What does Neonc Technologies Holdings, . do?
Neonc Technologies Holdings, Inc. is a life sciences company pioneering a new era in brain health by revolutionizing the treatment of Central Nervous System (CNS) diseases. They have developed a proprietary, patented platform technology designed to transport therapeutics directly to the brain, overcoming the limitations of the Blood-Brain Barrier. This technology aims to deliver more effective treatments for CNS diseases, including brain cancers, and is based on their proprietary synthesis of Pe…
What is Neonc Technologies Holdings, .'s revenue?
StartupHub estimates Neonc Technologies Holdings, .'s annual revenue at $1.1M (range $688K to $2.0M, 62% confidence), based on comparable companies in the sector.
What industry does Neonc Technologies Holdings, . operate in?
Neonc Technologies Holdings, . operates in MedTech, HealthTech, Drug Discovery, Clinical Trials, Biotech, Neurotech.
How many employees does Neonc Technologies Holdings, . have?
Neonc Technologies Holdings, . has approximately 9 people on record.
Does Neonc Technologies Holdings, . have an affiliate program?
Yes, Neonc Technologies Holdings, . has an affiliate program. The program runs on Self-hosted affiliate. Register here: https://neonc.com/affiliates
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“The company is a clinical-stage biopharmaceutical business, developing treatments for brain cancers. It is offering 2.95M shares, expecting proceeds. The money will be used for general corporate purposes.”
View on Reddit“The company, formed in 2008, is a clinical-stage biopharmaceutical business developing treatments for brain cancers. It has two lead products: NEO100, delivered intranasally, and NEO212.”
View on Reddit“NeOnc Technologies found that ultrasound enhances NEO100's effectiveness in treating brain tumors, according to preclinical research at USC. AI-driven study showed increased tumor-killing activity using NEO100 with focused ultrasound.”
View on Reddit“The President, a Director, and a 10% Owner, Amir F Heshmatpour, executed multiple open-market purchases totaling approximately $185,000, reinforcing his already substantial position in the company. Market Impact : This series of buys is a b…”
View on Reddit“NeOnc Technologies reported Q3 2025 results, highlighted operational updates including NEO100 Phase 2a data, FDA clearance for NEO212, and a $50M strategic partnership, with key milestones anticipated.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.